IBDEI1YB ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34622,1,3,0)
 ;;=3^Nicotine Dependence,Chewing Tobacco,In Remission
 ;;^UTILITY(U,$J,358.3,34622,1,4,0)
 ;;=4^F17.221
 ;;^UTILITY(U,$J,358.3,34622,2)
 ;;=^5003371
 ;;^UTILITY(U,$J,358.3,34623,0)
 ;;=F17.220^^192^2005^5
 ;;^UTILITY(U,$J,358.3,34623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34623,1,3,0)
 ;;=3^Nicotine Dependence,Chewing Tobacco,Uncomplicated
 ;;^UTILITY(U,$J,358.3,34623,1,4,0)
 ;;=4^F17.220
 ;;^UTILITY(U,$J,358.3,34623,2)
 ;;=^5003370
 ;;^UTILITY(U,$J,358.3,34624,0)
 ;;=F17.211^^192^2005^6
 ;;^UTILITY(U,$J,358.3,34624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34624,1,3,0)
 ;;=3^Nicotine Dependence,Cigarettes,In Remission
 ;;^UTILITY(U,$J,358.3,34624,1,4,0)
 ;;=4^F17.211
 ;;^UTILITY(U,$J,358.3,34624,2)
 ;;=^5003366
 ;;^UTILITY(U,$J,358.3,34625,0)
 ;;=F17.210^^192^2005^7
 ;;^UTILITY(U,$J,358.3,34625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34625,1,3,0)
 ;;=3^Nicotine Dependence,Cigarettes,Uncomplicated
 ;;^UTILITY(U,$J,358.3,34625,1,4,0)
 ;;=4^F17.210
 ;;^UTILITY(U,$J,358.3,34625,2)
 ;;=^5003365
 ;;^UTILITY(U,$J,358.3,34626,0)
 ;;=F17.291^^192^2005^8
 ;;^UTILITY(U,$J,358.3,34626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34626,1,3,0)
 ;;=3^Nicotine Dependence,Oth Tobacco Product,In Remission
 ;;^UTILITY(U,$J,358.3,34626,1,4,0)
 ;;=4^F17.291
 ;;^UTILITY(U,$J,358.3,34626,2)
 ;;=^5003376
 ;;^UTILITY(U,$J,358.3,34627,0)
 ;;=F17.290^^192^2005^9
 ;;^UTILITY(U,$J,358.3,34627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34627,1,3,0)
 ;;=3^Nicotine Dependence,Oth Tobacco Product,Uncomplicated
 ;;^UTILITY(U,$J,358.3,34627,1,4,0)
 ;;=4^F17.290
 ;;^UTILITY(U,$J,358.3,34627,2)
 ;;=^5003375
 ;;^UTILITY(U,$J,358.3,34628,0)
 ;;=F17.201^^192^2005^10
 ;;^UTILITY(U,$J,358.3,34628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34628,1,3,0)
 ;;=3^Nicotine Dependence,Unspec,In Remission
 ;;^UTILITY(U,$J,358.3,34628,1,4,0)
 ;;=4^F17.201
 ;;^UTILITY(U,$J,358.3,34628,2)
 ;;=^5003361
 ;;^UTILITY(U,$J,358.3,34629,0)
 ;;=F17.200^^192^2005^11
 ;;^UTILITY(U,$J,358.3,34629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34629,1,3,0)
 ;;=3^Nicotine Dependence,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,34629,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,34629,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,34630,0)
 ;;=F19.20^^192^2005^15
 ;;^UTILITY(U,$J,358.3,34630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34630,1,3,0)
 ;;=3^Psycoactive Substance Dependence,Uncomplicated
 ;;^UTILITY(U,$J,358.3,34630,1,4,0)
 ;;=4^F19.20
 ;;^UTILITY(U,$J,358.3,34630,2)
 ;;=^5003431
 ;;^UTILITY(U,$J,358.3,34631,0)
 ;;=F43.11^^192^2005^12
 ;;^UTILITY(U,$J,358.3,34631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34631,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,34631,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,34631,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,34632,0)
 ;;=F43.12^^192^2005^13
 ;;^UTILITY(U,$J,358.3,34632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34632,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,34632,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,34632,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,34633,0)
 ;;=F43.10^^192^2005^14
 ;;^UTILITY(U,$J,358.3,34633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34633,1,3,0)
 ;;=3^PTSD,Unspec
 ;;^UTILITY(U,$J,358.3,34633,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,34633,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,34634,0)
 ;;=L40.2^^192^2006^1
 ;;^UTILITY(U,$J,358.3,34634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34634,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,34634,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,34634,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,34635,0)
 ;;=L03.91^^192^2006^2
